Provided by Tiger Trade Technology Pte. Ltd.

BioCardia

1.01
+0.04294.44%
Post-market: 1.00-0.0100-0.99%19:31 EDT
Volume:82.46K
Turnover:81.48K
Market Cap:15.03M
PE:-1.37
High:1.02
Open:0.9730
Low:0.9560
Close:0.9671
52wk High:2.29
52wk Low:0.7500
Shares:14.88M
Float Shares:12.27M
Volume Ratio:0.37
T/O Rate:0.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7393
EPS(LYR):-1.2341
ROE:-1803.19%
ROA:-134.97%
PB:5.57
PE(LYR):-0.82

Loading ...

BioCardia Inc expected to post a loss of 16 cents a share - Earnings Preview

Reuters
·
May 14

BioCardia schedules first-quarter earnings conference call, corporate update

Reuters
·
May 12

BioCardia provides update on Helix pre-submission meeting with FDA

TIPRANKS
·
May 09

BioCardia Inc expected to post a loss of 16 cents a share - Earnings Preview

Reuters
·
May 08

BioCardia Inc - FDA Prefers Helix Approval Simultaneous With Cardiamp Cell Therapy System Approval

THOMSON REUTERS
·
May 08

BioCardia and FDA Align on Helix Transendocardial Delivery Catheter Clearance Pathways

THOMSON REUTERS
·
May 08

BioCardia Inc - FDA Agrees on Two Pathways for Helix Marketing Clearance, No Safety Concerns Raised

THOMSON REUTERS
·
May 08

BioCardia Inc - FDA Suggests Follow-on Pre-Submission Could Enable Helix Approval via Denovo Pathway

THOMSON REUTERS
·
May 08

BioCardia CEO Peter Altman acquires 5,000 common shares for $5,550

Reuters
·
Apr 30

BioCardia Gains Japanese Patent for Heart3D Imaging Technology

TIPRANKS
·
Apr 28

BioCardia says Japan allows patent for Heart3D fusion imaging software

Reuters
·
Apr 28

BioCardia Announces Allowance of Japanese Patent on Proprietary Heart3d™ Fusion Imaging Software for Procedure Planning and Realtime Navigation During Cardiamp Cell Therapy Procedures

THOMSON REUTERS
·
Apr 28

BioCardia CEO Peter Altman buys $1,230 common shares

Reuters
·
Apr 23

BioCardia reports ‘positive’ outcome in consult with Japan’s PMDA for CardiAMP

TIPRANKS
·
Apr 20

BioCardia says Japan PMDA deems CardiAMP data sufficient for market clearance

Reuters
·
Apr 20

BioCardia gets Nasdaq notice for failing $2.5 million stockholders’ equity rule

Reuters
·
Apr 16

BioCardia Inc - Expects FDA Meeting This Quarter Under Breakthrough Designation for Cardiamp System

THOMSON REUTERS
·
Apr 02

BioCardia Inc - Submits Cardiamp HF Clinical Study Data to FDA - SEC Filing

THOMSON REUTERS
·
Apr 02

BioCardia seeks FDA meeting on accelerated approval pathway for CardiAMP in heart failure

Reuters
·
Apr 02

Press Release: Tamboran Farmout Pilot Area and BCDA Acreage for Significant Premium in Acreage Value

Dow Jones
·
Mar 30